Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support

Annals of Oncology

Volumn 10, Issue 10, 1999, Pages 1207-1209

  Advani, R ^a   Warnke, R ^a   Rosenberg, S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

High dose chemotherapy; Multicentric Castleman's disease; Non Hodgkin's lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; PREDNISONE; STEROID; VINCRISTINE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE BIOPSY; MALE; MULTIPLE CANCER; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; STEROID THERAPY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; GIANT LYMPH NODE HYPERPLASIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; PROGNOSIS; TREATMENT OUTCOME;

EID: 0032744427     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008366721816     Document Type: Article

References (28)

1. Castleman R, Iverson L, Menendez V. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956; 9: 822-30.
2. Keller AR, Hochholzer L, Castleman B. Hyaline vascular and plasma cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972; 29: 670-83.
3. McCarty MJ, Vukelja SJ, Banks P et al. Angiofollicular Lymph Node Hyperplasia (Castleman's disease). Cancer Treat Rev 1985; 21: 291-310.
4. Peterson B, Frizzerra G. Multicentric Castleman's disease. Semin Oncol 1993; 20 (6): 636-47.
5. Weisenberger DD, Nathwani BN, Winberg CD et al. Multicentric Angiofollicular lymph node hyperplasia. A clinicopathologic study of 16 cases. Hum Pathol 1985; 16: 162-72.
6. Frizzera G, Massserelli G, Banks PM et al. A systemic lymphoproliferative disorder with morphological features of Castleman's disease - pathological findings in 15 patients. Am J Surg Pathol 1983; 7: 211-31.
7. Menke DM, Camorias JK, Banks PM. Angiofollicular lymph node hyperplasia. A comparison of unicentric, multicentric, hyaline vascular and plasma cell types of disease by morphometric and clinical analysis. Modern Pathol 1992; 5: 525-30.
8. Shahidi H, Myers J, Kvale P. Castleman's disease. Mayo Clin Proc 1995; 70: 969-77.
9. Corbellino M, Poirel L, Aubin J et al. The role of human herpes virus 8 and Epstein-Barr virus in the pathoenesis of giant lymph node hyperplasia (Castleman's disease). Clin Infect Dis 1996; 6: 1120-1.
10. Herrada J, Cabanillas F, Rice L et al. The clinical behavior of localized and multicentric Castleman's disease. Ann Intern Med 1998; 328: 657-62.
11. Browne WD, Lewis JJ, Filippa DA et al. The management of unicentric and multicentric Castleman's disease: A report of 16 cases and a review of the literature. Cancer 1999; 85: 706-17.
12. Bartolli E, Massarelli G, Soggia G et al. Multicentric giant lymph node hyperplasia. A hyperimmune syndrome with a rapidly progressive course. Amer J Clin Pathol 1980; 73: 423-6.
13. Frizzera G, Peterson B, Bayrd ED et al. A systemic lymphoproliferative disorder with morphological features of Castleman's disease. Clinical findings and clinicopathologic correlation in 15 patients. J Clin Oncol 1985; 3: 1202-16.
14. Frizzera G. Castleman's disease and related disorders. Semin Diagnost Pathol 1988; 5: 346-64.
15. Leger-Ravet MB, Pauchmaur M, Devergne D et al. IL-6 gene expression in Castleman's disease. Blood 1991; 78: 923-30.
16. Brandt SJ, Bodine DM, Dunbar CE et al. Dysregulated IL 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 1990; 86: 592-9.
17. Parravinci C, Corbellino M, Paulli M et al. Expression of a virus derived cytokine, KSHV-vIL-6 in HIV and seronegative Castleman's disease. Am J Pathol 1997; 151: 1517-22.
18. Phatak P, Janas J, Sham R et al. Disorders that resemble lymphomas. Am J Hematol 1997; 56: 63-8.
19. Dickson D, Benezra JM, Reed J et al. Multicentric giant lymph node hyperplasia, Kaposi's sarcoma and lymphoma. Arch Pathol Lab Med 1985; 109: 1013-8.
20. Buckley JG, Sundaram M. Skeletal lymphoma in a patient with Castleman's disease. Am J Roentgenol 1991; 157: 1035-7.
21. Frizzera G. Castleman's disease: more questions than answers. Human Pathol 1985, 16: 202-5.
22. Franco V, Arasona F, Campesi G. Simultaneous development of giant lymph node hyperplasia and malignant non-Hodgkin's lymphoma. Acta Oncol 1986; 7 317-20.
23. Vasef M, Katzin WE, Mendelsohn G et al. Report of a case of localized Castleman's disease with progression to malignant lymphoma. Am J Pathol 1992, 98: 633-36.
24. Tamayo M, Gonzalez C, Majado MJ et al. Long term complete remission after interferon treatment in a case of multicentric Castleman's disease. Am J Hemat 1995, 49: 359-60.
25. Pavlidis NA, Briassoulis E, Klouvas G et al. Is Interferon an active agent in Castleman's disease? Ann Oncol 1992, 3: 85-6.
26. Bordeleau L, Bredeson C, Markman S. 2-chloro-deoxyadenosine therapy for giant lymph node hyperplasia. Br J Hematol 1995, 91: 668-70.
27. Repetto L, Jaiprakash MP, Selby PJ et al. Aggressive angiofollicular lymph node hyperplasia (Castleman's disease) Treatment with high dose melphelan and autologous bone marrow transplant. Hematol Oncol 1986, 4: 213-17.
28. Beck JT, Hsu S, Wijdenes J et al. Brief report; alleviation of systemic manifestations of Castleman's disease by monoclonal anti-Interleukin 6 antibody. New Engl J Med 1994, 330: 602-5.